![]() |
Trials |
A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients with Advanced or Unresectable Melanoma ProgressingCancer type: Melanoma Phase: I Principal Investigator: Nyakas Martha Country: NO Keywords: Norway, Oslo, oncolytic adenovirus, advanced or unresectable melanoma Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03003676 |